Take Solutions ends with 25% premium

1972 Investors following Take Solutions. Share this News with them.

0

Like this story, share it with millions of investors on M3

Take Solutions ends with 25% premium

Take Solutions, a company with a focus on life sciences and supply chain management solutions, has ended at Rs 910.05, up 24.66%, with volumes of 74,77,534 shares on the NSE.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Take Solutions sees FY09 profit at Rs 85-90 cr Take Solutions debuts with 21% premium Take Solutions BSE | NSE 25/05/12 Are Mutual Funds betting on Take Solutions?

Overall, it was a good session for new listing of Take Solutions , a company with a focus on life sciences and supply chain management solutions, which ended the day at Rs 910.05, up 24.66% on the NSE.

The stock has started morning trade with 21% premium at Rs 880 and touched a high/low of Rs 945.95 and Rs 831.30, respectively. In the beginning trade, it slipped below Rs 900 on the back of profit booking but as the markets started surging, the share also managed to cross Rs 900 and remained above that mark for the remaining period.

On the BSE, the share closed at Rs 926.5, with volumes of 56,53,526 shares. It has hit a high/low of Rs 943.30 and Rs 839.15, respectively.

It has gained 24.66% to end at Rs 910.05, with volumes of 74,77,534 shares and turnover at Rs 667.37 crore on the NSE.

In an interview with CNBC-TV18, H R Srinivasan , Vice Chairman and Prime Founder, Take Solutions said that he sees FY08 EPS at Rs 47-48 and revenues at Rs 320-330 crore. He sees FY09 profit at Rs 85-90 crore.

He said that the lifesciences segment contributes 46% of revenues and  supply chain 49%. The business is looking at completing one acquisition by Q4.

The company had come out with an initial public offer (IPO) of 2,100,000 equity shares of Rs 10 each for cash at a price band between Rs 675 and Rs 730 per equity share. It was subscribed 59.42 times.

Take Solutions offers cost effective comprehensive business solutions backed by domain expertise, in Supply Chain Management (SCM) and Life Sciences (LS).